← back to search

Susan Huson

University of Manchester · GB
Area of research
Neurology · Epidemiology
Research interest
Research interests include Neurofibromatosis and Schwannoma Cases, Meningioma and schwannoma management, Neuroblastoma Research and Treatments, and Genetic Neurodegenerative Diseases.
h-index
56
citations
14,611
works
177
NIH funding
primary concept
email

Recent publications

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
Genetics in Medicine 2022cited by 268position: middledoi
Revised diagnostic criteria and nomenclature for neurofibromatosis 2 and schwannomatosis: an international consensus recommendation (S27.003)
Neurology 2022cited by 12position: middledoi
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
Genetics in Medicine 2021cited by 744position: middledoi
Cutaneous neurofibromas
Neurology 2018cited by 112position: middledoi
Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1
JAMA Psychiatry 2016cited by 122position: middledoi
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials
Neurology 2016cited by 46position: middledoi
Current status and recommendations for biomarkers and biobanking in neurofibromatosis
Neurology 2016cited by 22position: middledoi
Clinical delineation and natural history of the <i>PIK3CA</i>‐related overgrowth spectrum
American Journal of Medical Genetics Part A 2014cited by 307position: middledoi
Autism Spectrum Disorder Profile in Neurofibromatosis Type I
Journal of Autism and Developmental Disorders 2014cited by 79position: middledoi
Recent developments in neurofibromatoses and RASopathies: Management, diagnosis and current and future therapeutic avenues
American Journal of Medical Genetics Part A 2014cited by 56position: middledoi
CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies
American Journal of Medical Genetics Part A 2014cited by 27position: middledoi
Mosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CA
Nature Genetics 2012cited by 319position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Eric Legius · ERN GENTURIS4 papers (2014–2022)D. Gareth Evans · Translational Research Institute3 papers (2014–2022)Shruti Garg · University of Manchester2 papers (2014–2016)P. Wolkenstein · Université Gustave Eiffel2 papers (2018–2022)Meena Upadhyaya · Cardiff University2 papers (2014–2018)Juha Peltonen · University of Helsinki2 papers (2014–2018)Scott R. Plotkin · Harvard University2 papers (2018–2022)David H. Gutmann · Lantmännen2 papers (2014–2016)Ellen Plasschaert · KU Leuven2 papers (2014–2016)Vincent M. Riccardi · Children's Hospital of Los Angeles2 papers (2014–2018) · 1 papers (2014–2014)Maria T. Acosta · University of California System1 papers (2016–2016)Marjorie J. Lindhurst · National Human Genome Research Institute1 papers (2012–2012)Luis F. Parada · Kettering University1 papers (2014–2014)Ludwine Messiaen · University of Alabama at Birmingham1 papers (2022–2022)David B. Savage · Cambridge University Hospitals NHS Foundation Trust1 papers (2012–2012)Stephen O’Rahilly · Wellcome/MRC Institute of Metabolic Science1 papers (2012–2012)Kathryn N. North · Loughborough University1 papers (2016–2016)Bruce R. Korf · University of Alabama at Birmingham1 papers (2018–2018)Annick Vogels · KU Leuven1 papers (2014–2014)